THERMAL CAUTERY PROBE

K050308 · Starion Instruments · HQR · Feb 25, 2005 · Ophthalmic

Device Facts

Record IDK050308
Device NameTHERMAL CAUTERY PROBE
ApplicantStarion Instruments
Product CodeHQR · Ophthalmic
Decision DateFeb 25, 2005
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 886.4100
Device ClassClass 2
AttributesTherapeutic

Intended Use

For the simultaneous cutting and cauterization of soft tissue during surgery.

Device Story

Single-use, handheld surgical instrument; used for simultaneous cutting and cauterization of soft tissue. Device features handle, finger/footswitch control, and power cord connecting to Starion Instruments power supply. Operated by surgeons in surgical settings. Surgeon positions probe in tissue region; device delivers thermal energy to perform cutting and coagulation. Benefits include reduced surgical time and improved hemostasis through simultaneous action.

Clinical Evidence

No clinical data provided; substantial equivalence based on technological characteristics and intended use.

Technological Characteristics

Handheld, single-use thermal cautery probe. Energy source: thermal (electrosurgical). Connectivity: wired connection to Starion Instruments power supply. Form factor: probe with handle and integrated finger/footswitch control.

Indications for Use

Indicated for simultaneous cutting and cauterization of soft tissue during surgery for patients requiring surgical intervention.

Regulatory Classification

Identification

A radiofrequency electrosurgical cautery apparatus is an AC-powered or battery-powered device intended for use during ocular surgery to coagulate tissue or arrest bleeding by a high frequency electric current.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ FEB 2 5 2005 ## Summary - 510(k)_K050308 Subject: Starion Instruments Thermal Cautery Probe Product: ## Summary: This summary of 510(k) safety and effectiveness data is being submitted in accordance with the requirements of 21 CFR 807.92. The Starion Instruments Thermal Cautery Probe is a single use, handheld surgical instrument intended for simultaneous cutting and cauterization of soft tissue during surgery. The Food and Drug Administration has classified electrosurgical cutting and coagulating devices as Class II devices (21 CFR 878.4400). The Starion Instruments Universal Thermal Cautery Probe is substantially equivalent in terms of intended use, target population, energy source, and principles of operation to the Starion Instruments Thermal Cautery Hook, a legally marketable predicate device which has been granted marketing clearance via K000296. The Starion Instruments Thermal Cautery Probe allows the surgeon to position the probe in the region of tissue to be cauterized. The Thermal Cautery Probe features a handle, a finger/footswitch control and power cord for connection to a Starion Instruments power supply. Binay Lim Brian Grigsby - Submitter/Contact Person Vice President of Quality, Regulatory Affairs and Operations Starion Instruments Corporation 20665 Fourth Street Saratoga, CA 95070 Phone (408) 741-8773 Fax -(408) 741-8774 2/1/05 Date Date {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features the department's name arranged in a circular pattern around a stylized emblem. The emblem consists of a stylized caduceus, a symbol often associated with medicine and healthcare, with three parallel lines representing the branches of government. FEB 2 5 2005 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mr. Brian Grigsby Vice President of Quality, Regulatory Affairs and Operations Starion Instruments Corporation 20665 Fourth Street Saratoga, California 95070 Re: K050308 Trade/Device Name: Starion Instruments Thermal Cautery Regulation Number: 21 CFR 886.4100 Regulation Name: Radiofrequency electrosurgical cautery apparatus Regulatory Class: II Product Code: HQR Dated: February 4, 2005 Received: February 9, 2005 Dear Mr. Grigsby: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act`s requirements, including. but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {2}------------------------------------------------ Page 2 - Mr. Brian Grigsby This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Miriam C Provost Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ 510(k) NUMBER (IF KNOWN): __ K OS O 3 O 8 DEVICE NAME: ________ Thermal Cautery Probe INDICATIONS FOR USE: For the simultaneous cutting and cauterization of soft tissue during surgery. Prescription Use (Per 21 CFR 901.109) OR Over-The-Counter Use (Optional Format 1-2-96) (PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Miriam C. Provost (Division Sign-Off) Division of General, Restorative, and Neurological Devices 510(k) Number 650308 Page 1 of 1
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%